Journal
CURRENT OPINION IN CELL BIOLOGY
Volume 24, Issue 6, Pages 744-756Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.ceb.2012.10.004
Keywords
-
Categories
Funding
- NIH [P01 GM099130]
- Ellison Medical Foundation Senior Scholar Award
- Glenn Foundation for Medical Research
- EMBO
Ask authors/readers for more resources
Aging is accompanied by the functional decline of cells, tissues, and organs, as well as a striking increase in a wide range of diseases. The reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) opens new avenues for the aging field and has important applications for therapeutic treatments of age-related diseases. Here we review emerging studies on how aging and age-related pathways influence iPSC generation and property. We discuss the exciting possibility that reverting to a pluripotent stem cell stage erases several deficits associated with aging and offers new strategies for rejuvenation. Finally, we argue that reprogramming provides a unique opportunity to model aging and perhaps exceptional longevity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available